USING BEST-WORST SCALING IN HORIZON SCANNING FOR HEPATOCELLULAR CARCINOMA TECHNOLOGIES

‘The usefulness of Bayesian optimal designs for discrete choice experiments’ by R. Kessels, B. Jones, P. Goos and M. Vandebroek

(2011) John M. Rose   APPLIED STOCHASTIC MODELS IN BUSINESS AND INDUSTRY

Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies

(2011) R. Lord et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Targeted therapy of hepatocellular cancer

(2010) Piotr Jan Wysocki   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Current Approaches to the Treatment of Early Hepatocellular Carcinoma

(2010) S.-L. Ye et al.   ONCOLOGIST

Biomarker-adaptive clinical trial designs

(2010) Boris Freidlin et al.   PHARMACOGENOMICS

Current advances in tumor proteomics and candidate biomarkers for hepatic cancer

(2009) Xin-Qing Peng et al.   Expert Review of Proteomics

Differences in the identification process for new and emerging health technologies: Analysis of the EuroScan database

(2009) Nora Ibargoyen-Roteta et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics

(2009) Mohamed IF Shariff et al.   Expert Review of Gastroenterology & Hepatology

Early identification and assessment of new and emerging health technologies: Actions, progress, and the future direction of an international collaboration—EuroScan

(2008) Sue Simpson et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE